The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,3R)-3-(4-(6-methoxypyridin-2-yl)-1H-imidazol-2-yl)-1-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole ID: ALA3775387
PubChem CID: 127031432
Max Phase: Preclinical
Molecular Formula: C25H27N5O2
Molecular Weight: 429.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)n1
Standard InChI: InChI=1S/C25H27N5O2/c1-31-22-8-4-7-19(27-22)21-14-26-25(30-21)20-13-17-16-5-2-3-6-18(16)28-24(17)23(29-20)15-9-11-32-12-10-15/h2-8,14-15,20,23,28-29H,9-13H2,1H3,(H,26,30)/t20-,23-/m1/s1
Standard InChI Key: XKECADRQWWLRNM-NFBKMPQASA-N
Molfile:
RDKit 2D
32 37 0 0 0 0 0 0 0 0999 V2000
-3.7006 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7006 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.3190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 -0.6045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0335 1.5807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1716 3.0613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6389 3.3729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3886 2.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3847 0.9592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4684 -2.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7672 -3.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7663 -5.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4668 -5.8201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1682 -5.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1691 -3.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8811 1.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8479 3.0569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3236 2.7880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8286 1.3755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8579 0.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3822 0.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2972 3.9301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4775 3.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
12 14 1 6
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
10 19 1 6
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
17 25 1 0
27 31 1 0
31 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 429.52Molecular Weight (Monoisotopic): 429.2165AlogP: 4.32#Rotatable Bonds: 4Polar Surface Area: 87.85Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.64CX Basic pKa: 7.45CX LogP: 3.60CX LogD: 3.28Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -0.24
References 1. He S, Dobbelaar PH, Guo L, Ye Z, Liu J, Jian T, Truong Q, Shah SK, Du W, Qi H, Bakshi RK, Hong Q, Dellureficio JD, Sherer E, Pasternak A, Feng Z, Reibarkh M, Lin M, Samuel K, Reddy VB, Mitelman S, Tong SX, Chicchi GG, Tsao KL, Trusca D, Wu M, Shao Q, Trujillo ME, Fernandez G, Nelson D, Bunting P, Kerr J, Fitzgerald P, Morissette P, Volksdorf S, Eiermann GJ, Li C, Zhang BB, Howard AD, Zhou YP, Nargund RP, Hagmann WK.. (2016) SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists., 26 (6): [PMID:26898814 ] [10.1016/j.bmcl.2016.02.022 ]